Medicare Part D can cover Litfulo, but whether your specific plan does depends on its formulary, and coverage almost always comes with prior authorization and step therapy requirements. If your plan does cover ritlecitinib, the 2026 out-of-pocket cap means you will not pay more than $2,100 for the year, no matter what the pharmacy’s sticker price looks like.
Litfulo runs roughly $4,300 to $4,700 for a 28-day supply at retail.1Drugs.com. Litfulo Price Guide2GoodRx. Litfulo Prices, Coupons, and Patient Assistance That price is why the coverage questions matter so much, and why the answers below focus on how to get a plan to pay and what to do when it won’t.
Why Coverage Varies by Plan
No Medicare rule forces every Part D plan to cover Litfulo. Each plan sets its own formulary, and plans have wide discretion over drugs that fall outside Medicare’s six protected classes (immunosuppressants, antidepressants, antipsychotics, anticonvulsants, antiretrovirals, and antineoplastics).3PAN Foundation. Understanding the Medicare Part D Cap Alopecia areata treatments are not in any of those categories.
There is a second wrinkle. Medicare’s prescription drug benefit manual still lists “agents when used for cosmetic purposes or hair growth” as excluded from Part D. The manual carves out exceptions for psoriasis, acne, rosacea, and vitiligo, but not for alopecia areata.4Medicare Interactive. Drugs Excluded From Part D Coverage Some plans invoke that exclusion to deny Litfulo. The counter-argument, which your dermatologist can make in writing, is that Litfulo is FDA-approved specifically to treat severe alopecia areata as a medical condition, not for cosmetic purposes.
To check your own plan, use the Medicare Plan Finder at Medicare.gov and search by drug name. Formularies change each year, so the best time to shop for a plan with better coverage is open enrollment, October 15 through December 7.5GoodRx. Litfulo Medicare Coverage
What You Pay When Your Plan Covers Litfulo
Part D in 2026 has three phases:6Medicare.gov. Part D Costs
- Deductible phase: you pay full price until you hit your plan’s deductible, which can run up to $615.
- Initial coverage: you pay 25 percent coinsurance on covered drugs until your out-of-pocket spending reaches $2,100.
- Catastrophic phase: once you hit $2,100, you pay $0 for covered Part D drugs for the rest of the year.
The $2,100 annual cap comes from the Inflation Reduction Act’s Part D redesign, which started at $2,000 in 2025 and is indexed up each year.7CMS. Final CY 2026 Part D Redesign Program Instructions For a drug priced above $4,000 per month, that math is simple: 25 percent of one fill blows past the cap. You will owe the full $2,100 for the year, and nothing after.
The catch is timing. Without any planning, that $2,100 can land on you in January, at your first fill.
Spreading the Cost Across the Year
Medicare’s Prescription Payment Plan, launched in 2025, lets Part D enrollees pay out-of-pocket costs in monthly installments through their plan instead of all at once at the pharmacy.8Medicare.gov. What’s the Medicare Prescription Payment Plan It charges no interest. The total you owe does not change; the bill just arrives in pieces.
Enrolling earlier in the year means more months to divide the cost over. If you opted in during 2025 and stay with the same plan, your participation renews automatically for 2026. If you switch plans, you have to re-enroll.9PAN Foundation. Understanding the Medicare Prescription Payment Plan Fall two months behind on payments and the plan can remove you from the program; you stay in your Part D plan but you owe the balance.10AARP. Medicare Prescription Payment Plan
For 2026, enrollment in the payment plan is also a prerequisite if you want to apply to Pfizer’s Patient Assistance Program (more on that below).
Prior Authorization: What Your Plan Will Likely Require
Even when Litfulo is on a plan’s formulary, approval comes with conditions. The criteria vary by plan, but one major health plan’s requirements are representative:11Kaiser Permanente. Litfulo Formulary Criteria
- A dermatologist must write the prescription.
- Diagnosis of alopecia areata with at least 50 percent hair loss.
- Patient at least 12 years old.
- Documented trial and failure of (or intolerance to) squaric acid dibutyl ester, plus at least three of: intralesional steroids, topical steroids, methotrexate, azathioprine, cyclosporine, sulfasalazine, or mycophenolate.
- For continued coverage, the dermatologist must confirm the patient is responding. Approvals typically run in 12-month increments.
Expect your plan to want evidence of severe disease, dermatologist involvement, and failure of cheaper treatments before approving a JAK inhibitor at this price.
If Your Plan Denies Coverage
Denials are routine for specialty drugs, and alopecia areata treatments face the extra hurdle of the cosmetic-use language. You have options.
Formulary Exception Request
If Litfulo is not on your plan’s formulary, you can request an exception. Your prescriber must submit a supporting statement explaining that covered alternatives would be less effective or harmful for you.12CMS. Part D Exceptions Once the plan has that statement, it must respond within 72 hours for a standard request or 24 hours for an expedited one.
Appeals
If the exception is denied, you have 60 days to appeal. The levels you are most likely to use:13Medicare Interactive. Introduction to Part D Appeals
- Level 1, plan redetermination: decision within 7 days, or 72 hours if expedited.
- Level 2, Independent Review Entity: decision within 7 days, or 72 hours if expedited.
- Higher levels (administrative law judge, Medicare Appeals Council, federal court) exist with their own dollar thresholds and timelines.14Medicare.gov. Medicare Appeals
Pfizer’s dermatology patient access team helps patients with prior authorization paperwork, letters of medical necessity, and appeals. The number is 1-833-956-3376.15Pfizer. Guide to Getting Litfulo The National Alopecia Areata Foundation has reported that roughly 40 percent of denied alopecia areata insurance claims win on appeal.16Healthline. Alopecia Areata Financial Costs
Financial Help When You’re on Medicare
One thing to know upfront: Pfizer’s Litfulo Copay Savings Card and Interim Care Rx program, which can bring costs to $0, are not available to you if you have Medicare, Medicaid, TRICARE, or any other government insurance.17Litfulo.com. Litfulo Savings and Support Sign-Up18Litfulo.com. Litfulo Copay Savings Card Rebate Terms Those exclusions are federal rules, not plan rules, so there is no workaround through your Part D plan.
What Medicare beneficiaries can use:
Pfizer Patient Assistance Program
Unlike the copay card, Pfizer’s Patient Assistance Program accepts government-insured patients. To qualify, your pre-tax household income must be at or below 300 percent of the Federal Poverty Level, and you need a valid prescription for an FDA-approved use.19Pfizer Rx Pathways. Our Programs Eligible patients get the medication free.
For 2026, Medicare enrollees have added requirements: you must enroll in the Medicare Prescription Payment Plan first, apply for other funding sources, and submit proof of income (W-2 or tax return) with a form signed by you and your provider.20Pfizer Rx Pathways. Pfizer Rx Pathways Updates If you have already hit your $2,100 cap and are paying $0 at the pharmacy, you are not eligible, because the program has nothing left to cover.
Extra Help
Medicare’s Extra Help program (the Low-Income Subsidy) cuts prescription costs sharply for beneficiaries with limited income and resources. In 2026, qualifying beneficiaries pay no more than $12.65 per brand-name prescription, owe no plan premium or deductible, and pay $0 once total drug costs reach $2,100.21Medicare.gov. Get Help With Drug Costs Income limits for 2026 are $23,940 for an individual and $32,460 for a married couple, with resource limits of $18,090 and $36,100. Pfizer’s patient access team will screen you for Extra Help eligibility if you ask.22Pfizer Dermatology Patient Access. Financial Support
Charitable Foundations
Independent charities like the Patient Advocate Foundation and PAN Foundation run disease-specific copay funds that Medicare beneficiaries can legally use. As of the most recent available information, alopecia areata is not among the conditions with an active fund at the Patient Advocate Foundation.23Washington State Department of Health. Patient Advocate Foundation Co-Pay Relief Funds open and close with donations, so it is worth checking back.
If Litfulo Isn’t Covered, Check the Other JAK Inhibitors
Litfulo is one of three FDA-approved JAK inhibitors for severe alopecia areata. Olumiant (baricitinib), approved for adults in June 2022, runs roughly $2,700 to $5,500 per month depending on dose.16Healthline. Alopecia Areata Financial Costs Leqselvi (deuruxolitinib) was approved in July 2024 for adults 18 and older.24National Alopecia Areata Foundation. FDA-Approved JAK Inhibitors All three carry prior authorization and step therapy hurdles under Medicare, but formularies differ enough that your plan may cover one when it will not cover another. Older JAK inhibitors like tofacitinib (Xeljanz) are sometimes used off-label, though off-label use typically makes coverage harder, not easier.